[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Sufentanil (CAS 56030-54-7) Market Research Report 2024

July 2024 | 70 pages | ID: S37B63A2254EN
BAC Reports

US$ 2,200.00 US$ 2,650.00 -17 %
Offer valid until July 31, 2024!

Email Delivery - PDF (on default)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question

Sufentanil (CAS 56030-54-7) Market Research Report 2024 presents comprehensive data on Sufentanil markets globally and regionally (Europe, Asia, North America etc.)

The report includes Sufentanil description, covers its application areas and related patterns. It overviews Sufentanil market, names Sufentanil producers and indicates its suppliers.

Besides, the report provides Sufentanil prices in regional markets.

In addition to the above the report determines Sufentanil consumers in the market.

BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS).

We can analyze the following elements for each chemical product in any country or region:

  • capacities and production
  • consumption volume and structure
  • market price trends
  • exports and imports
  • existing technologies
  • feedstock market condition
  • market news digest
  • market forecast.

Sufentanil (CAS 56030-54-7) Market Research Report 2024 can feature:

  • market condition and estimations, market forecast
  • chemical product ranges, trademarks, analogous products, application areas
  • regional and global producers, consumers and traders (including contact details).

1. SUFENTANIL (CAS 56030-54-7)

1.1. General information, synonyms
1.2. Composition, chemical structure
1.3. Safety information
1.4. Hazards identification
1.5. Handling and storage
1.6. Toxicological & ecological information
1.7. Transport information

2. SUFENTANIL APPLICATIONS

2.1. Sufentanil application spheres, downstream products

3. SUFENTANIL MANUFACTURING METHODS

4. SUFENTANIL PATENTS

Abstract
Description
Summary of the invention
Detailed description of the invention

5. SUFENTANIL MARKET WORLDWIDE 

5.1. General Sufentanil market situation, trends
5.2. Manufacturers of Sufentanil
- Europe
- Asia
- North America
- Other regions
5.3. Sufentanil suppliers (importers, local distributors)
- Europe
- Asia
- North America
- Other regions
5.4. Sufentanil market forecast

6. SUFENTANIL MARKET PRICES

6.1. Sufentanil prices in Europe
6.2. Sufentanil prices in Asia
6.3. Sufentanil prices in North America
6.4. Sufentanil prices in other regions

7. SUFENTANIL END-USE SECTOR 

7.1. Sufentanil market by application sphere
7.2. Sufentanil downstream markets trends and prospects

*Please note that Sufentanil (CAS 56030-54-7) Market Research Report 2024 is a half ready publication and contents are subject to change. It only requires updating with the help of new data that are constantly retrieved from Publisher’s databases and other sources. This updating process takes 5-7 business days after order is placed. Thus, our clients always obtain a revised and updated version of each report. Please also note that we do not charge for such an updating procedure. BAC Reports has information for more than 25,000 different chemicals available but it is impossible to have all reports updated immediately. That is why it takes 5-7 days to update a report after an order is received.

Product Name:Sufentanil
Synonyms:
  • Streptonivicin
  • N-{4-(Methoxymethyl)-1-[2-(2-thienylethyl)]-4-piperidinyl}-N-phenylpropanamide
  • N-{4-(Methoxymethyl)-1-[2-(2-thienylethyl)]-4-piperidinyl}-propionanilide
CAS#:56030-54-7

Sufentanil (Chronogesic, Sufenta, Sufentanilum, Sufentanyl, Sulfentanil, Sulfentanyl, Sufentanil citrate) refers to a strong synthetic opioid analgesic with the molecular formula C22H30N2O2S. Sufentanil exists as white crystals from petroleum ether. First the product was synthesized in 1974. Sufentanil is the most lipid-soluble drug.

The drug is an opioid pain reliever that is used in anesthesia, in balanced anesthesia, and as a primary anesthetic agent during the surgery and medical procedures. Sufentanil is given as an injection into a muscle or intravenously. Moreover, the product is utilized for epidural anesthesia. Lipid solubility and ionization determine the rapid cell membrane penetration and onset of action of sufentanil. Sufentanil exhibits a very rapid onset of analgesia as the product is readily absorbed through mucosal tissues and distributed throughout the body. Opioid side effects of sufentanil can be increased because of active metabolites.

Irritation of eye tissue, narcotic effect, sedation, pinpoint pupils, mood alterations, nausea, vomiting, constipation, respiratory depression, dizziness, central nervous system depression are amid the most common side effects of sufentanil. Large doses of the product can cause respiratory or cardiac arrest and death.

Sufentanil market is covered in the study Sufentanil (CAS 56030-54-7) Market Research Report 2023. The report encompasses proper description of the product, unveils application areas, and briefly summarizes patents in the sphere. It overlooks sufentanil market situation, names manufacturers, suppliers as well as users. The report also provides current sufentanil prices in the market.


More Publications